Published in J Med Microbiol on February 01, 1999
Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus. J Clin Microbiol (2007) 1.65
Evaluation of performance of four genotypic methods for studying the genetic epidemiology of Aspergillus fumigatus isolates. J Clin Microbiol (2002) 1.41
Genetic polymorphism of Aspergillus fumigatus in clinical samples from patients with invasive aspergillosis: investigation using multiple typing methods. J Clin Microbiol (2001) 1.15
Simple chemical extraction method for DNA isolation from Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol (2004) 1.09
Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure. J Clin Microbiol (1999) 0.85
A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis (1999) 3.39
Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study. Eur J Surg Oncol (2013) 3.24
Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis (2004) 3.22
The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci U S A (1993) 2.94
Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother (2001) 2.69
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant (2011) 2.28
Responses in the start of Betula (birch) pollen seasons to recent changes in spring temperatures across Europe. Int J Biometeorol (2002) 2.21
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis (1999) 2.20
CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev (2000) 2.19
Aspergillus in pepper. Lancet (1989) 2.12
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Relationship between preoperative amiodarone treatment and complications observed during anaesthesia for valvular cardiac surgery. Can J Anaesth (1990) 2.08
Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol (1993) 2.06
Differentiation of Brevibacterium spp. encountered in clinical specimens. J Clin Microbiol (1994) 2.00
Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin Infect Dis (1996) 1.98
Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases. Int J Syst Bacteriol (1996) 1.74
Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis (1994) 1.72
Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2011) 1.69
Experience with itraconazole in cryptococcosis and aspergillosis. J Infect (1989) 1.69
New targets and delivery systems for antifungal therapy. Med Mycol (2000) 1.65
Identification of Fusarium species involved in human infections by 28S rRNA gene sequencing. J Clin Microbiol (1999) 1.63
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis (2015) 1.61
Emerging pathogens. Med Mycol (2000) 1.59
In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother (1999) 1.58
Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD. J Med Vet Mycol (1998) 1.57
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect (2011) 1.55
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother (1991) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect (2009) 1.46
Authorship ignorance: views of researchers in French clinical settings. J Med Ethics (2005) 1.46
Effectiveness of terbinafine in cutaneous alternariosis. Br J Dermatol (2000) 1.44
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol (1995) 1.44
Diagnosis of human hydatidosis: comparison between imagery and six serologic techniques. Am J Trop Med Hyg (1994) 1.44
Mycoses associated with AIDS in the Third World. Med Mycol (2000) 1.42
Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur J Clin Microbiol Infect Dis (1998) 1.41
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother (2006) 1.40
Turicella otitidis gen. nov., sp. nov., a coryneform bacterium isolated from patients with otitis media. Int J Syst Bacteriol (1994) 1.39
In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus. J Med Microbiol (1999) 1.39
Cost effectiveness of the induced sputum technique for the diagnosis of Pneumocystis carinii pneumonia (PCP) in HIV-infected patients. Eur Respir J (1993) 1.37
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J Clin Microbiol (1996) 1.35
Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1. J Clin Microbiol (1997) 1.35
Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus. Eur J Epidemiol (1993) 1.30
Origin of Cryptococcus neoformans var. neoformans diploid strains. J Clin Microbiol (2001) 1.28
Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation (1999) 1.27
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27
HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors. AIDS (1989) 1.24
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Ann Oncol (2005) 1.23
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev (2000) 1.23
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry (2008) 1.22
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob Agents Chemother (1996) 1.22
Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis (1994) 1.20
Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol (1997) 1.20
Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol (2001) 1.20
Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses (1997) 1.19
Hemodynamic and hormonal responses to hypothermic and normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth (1992) 1.17
Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol (2000) 1.17
Typing of Candida krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe. J Clin Microbiol (1994) 1.16
Molecular and genetic characterization of a serotype A MATa Cryptococcus neoformans isolate. Microbiology (2003) 1.16
Atypical strains of Candida albicans recovered from AIDS patients. J Med Vet Mycol (1997) 1.15
Genetic polymorphism of Aspergillus fumigatus in clinical samples from patients with invasive aspergillosis: investigation using multiple typing methods. J Clin Microbiol (2001) 1.15
Chemotaxonomy and molecular taxonomy of some coryneform clinical isolates. Zentralbl Bakteriol (1993) 1.15
Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol (2008) 1.12
Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology (2010) 1.12
Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients. J Clin Microbiol (2001) 1.11
Using bronchoscopy and biopsy to diagnose early inhalation injury. Macroscopic and histologic findings. Chest (1995) 1.10
Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol (1997) 1.10
Ribotyping: a tool for taxonomy and identification of the Nocardia asteroides complex species. J Clin Microbiol (1996) 1.10
Genotyping Cryptococcus neoformans var. neoformans with specific primers designed from PCR-fingerprinting bands sequenced using a modified PCR-based strategy. Med Mycol (2000) 1.10
Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant (2008) 1.10
Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome? J Chemother (2003) 1.09
Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32C. Ann Biol Clin (Paris) (1995) 1.08
Computed tomography of mediastinal lymph nodes in nonsmall cell lung cancer. A new approach based on the lymphatic pathway of tumor spread. J Comput Assist Tomogr (1988) 1.08
Review: norovirus prevalence in Belgian, Canadian and French fresh produce: a threat to human health? Int J Food Microbiol (2011) 1.07
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant (2011) 1.05
Fungal contamination in barley and Kashin-Beck disease in Tibet. Lancet (1997) 1.05
Candidosis in the intensive care unit: a 20-year survey. J Hosp Infect (2004) 1.05